GP-R

from $59.99

An investigational triple-receptor agonist targeting GIP, GLP-1, and glucagon pathways. Current research focuses on metabolic signaling, glucose regulation, energy balance, and related cardiometabolic markers.

Size:

An investigational triple-receptor agonist targeting GIP, GLP-1, and glucagon pathways. Current research focuses on metabolic signaling, glucose regulation, energy balance, and related cardiometabolic markers.

Tesamorelin